DYNAREX LAXATIVE

Manufacturer: Dynarex Corporation | Mistair Health & Hygiene Pvt Ltd
Effective date: 2014-03-05
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:38:53

Label at a glance#

ProductDYNAREX LAXATIVE

Active ingredientMINERAL OIL

Label structure9 sections

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient Purpose

Mineral oil Intestinal lubricant

Purpose

OTC - PURPOSE SECTION

Purpose

Relieves occassional constipation (irregularity).

Warnings

WARNINGS SECTION

Warnings

Do not use:

If you have difficulty swallowing.
In children under 12 years of age.
If you are pregnant.
For a period longer than 1 week.
If you are bedridden or aged.

Indications & Usage

INDICATIONS & USAGE SECTION

Indications & Usage

For relief of occassional constipation (irregularity).

When using this product

Do not take with meals
Take only at bedtime

Ask a doctor before use if you have

Stomach reflux
Abdominal pain, nausea, or vomiting
Notice a sudden change in bowel habits that persist over a period of 2 weeks

Stop use and ask a doctor if

Rectal bleeding or failure to have a bowel movementafter use. These could be signs of a serious condition.

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Directions

Do not take with meals
Take only at bedtime
May be taken as a single daily dose or in divided doses.

age

dose

adults and children

over 12 years

1 to 3 tablespoons (15 to 45 ml)

Maximum 3 tablespoons (45ml) in 24 hours

children under

12 years

Consult a doctor

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep Out Of Reach Of Children

Keep this and all drugs out of the reach of children
In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Other information

SPL UNCLASSIFIED SECTION

Other information

Keep tightly closed

Protect from sunlight

Inactive ingredients

INACTIVE INGREDIENT SECTION

Inactive ingredients: Butylated hydroxytoluene (BHT), Butylated hydroxyanisole (BHA)

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dynarex Mineral Oil Laxative
4270 Min oil.jpg

4270 Mineral oil

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
705909	mineral oil 99.9 % Oral Solution	PSN	1
705909	mineral oil 999 MG/ML Oral Solution	SCD	1
705909	mineral oil 99.9 % Oral Solution	SY	1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
67777-404-01	2019-11-27	C162847	48780-1	9855e2a2-4773-60a7-e053-dbdaa90a05bd	Dynarex Mineral Oil Laxative

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
67777-404-01	DYNAREX LAXATIVE	473 g in 1 BOTTLE	LIQUID	473		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
67777-404	DYNAREX LAXATIVE (MINERAL OIL) LIQUID [DYNAREX CORPORATION]	1	Legacy NDC, 1 package rows	20140402_a56267f3-2a8b-4a70-9ce5-233ddbf13db6.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
MINERAL OIL	ACTIVE INGREDIENT	T5L8T28FGP	1
MINERAL OIL	ACTIVE MOIETY	T5L8T28FGP	1
Butylated hydroxyanisole	INACTIVE INGREDIENT	REK4960K2U	1
butylated hydroxytoluene	INACTIVE INGREDIENT	1P9D0Z171K	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

DYNAREX LAXATIVE
MINERAL OIL
butylated hydroxytoluene
Butylated hydroxyanisole

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
67777-404	67777-404-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MINERAL OIL	T5L8T28FGP	ACTIB
butylated hydroxytoluene	1P9D0Z171K	IACT
Butylated hydroxyanisole	REK4960K2U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 56 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	0.02 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SOAP / TOPICAL	0.02 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET, FOR SUSPENSION / ORAL	0.1 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SHAMPOO / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	SOLUTION / ORAL		5 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	OINTMENT / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	AEROSOL, FOAM / TOPICAL		4 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CAPSULE, LIQUID FILLED / ORAL	0.1 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET / ORAL		3 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SPRAY, METERED / NASAL	0.1 mg/1ml		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	SYRUP / ORAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	FILM, SOLUBLE / ORAL	0.06 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CREAM, AUGMENTED / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	CONCENTRATE / ORAL	0.08 mg/1ml		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET / ORAL		8 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	LOTION / TOPICAL		1000 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SWAB / TOPICAL	0.5 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CAPSULE / ORAL		3 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SPRAY / TOPICAL		3 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE, LIQUID FILLED / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET / SUBLINGUAL	0.13 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	CREAM / VAGINAL	0.03 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	GEL / TOPICAL		8 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CREAM / VAGINAL	0.05 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	LOTION / TOPICAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUPPOSITORY / RECTAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SOLUTION, CONCENTRATE / ORAL	0.1 mg/1ml		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	OINTMENT / VAGINAL	0.02 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUPPOSITORY / VAGINAL	1 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CREAM / TOPICAL		6 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	CREAM / TOPICAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUSPENSION / ORAL	2.5 mg/5ml		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	GRANULE, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	GUM, CHEWING / BUCCAL		5 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET / SUBLINGUAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, FILM COATED / ORAL	0.4 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	FILM / SUBLINGUAL	0.08 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SOLUTION / TOPICAL		3 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	GEL, METERED / TOPICAL		4 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
Butylated hydroxyanisole	BUTYLATED HYDROXYANISOLE	REK4960K2U	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CAPSULE, EXTENDED RELEASE / ORAL	0.03 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SUPPOSITORY / RECTAL		1 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
butylated hydroxytoluene	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	OINTMENT / TOPICAL		57 mg	Exact identifier — unii candidate 32 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
4b1b8aeb-f368-46a2-8bfd-516e2a1436b9			a56267f3-2a8b-4a70-9ce5-233ddbf13db6	2014-03-05	Warnings	Exact identifier spl id: 4b1b8aeb-f368-46a2-8bfd-516e2a1436b9 spl set id: a56267f3-2a8b-4a70-9ce5-233ddbf13db6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.